文献速递瓣膜外科

风湿性患者二尖瓣置换同期三尖瓣环成形术的远期结局

Long-Term Outcomes After Mitral Valve Replacement and Tricuspid Annuloplasty in Rheumatic Patients.
PubMed 文献 · Ann Thorac Surg · 2018-10-25

单中心回顾性研究纳入285例风湿性心脏病患者,比较单纯二尖瓣置换(147例)与同期三尖瓣环成形(138例)的远期结局。中位随访10.8年,同期三尖瓣环成形与三尖瓣反流分级改善的 odds 增加3.4倍相关,且术前中重度三尖瓣反流患者获得独立远期生存获益(HR 0.44,95%CI 0.23–0.87,p=0.018)。

要点

  • 风湿性二尖瓣置换同期三尖瓣环成形可改善远期三尖瓣反流分级。
  • 术前中重度三尖瓣反流者同期成形与远期生存获益独立相关。
  • 研究为单中心回顾性设计,结论需前瞻性验证。

核心结论

  • 风湿性心脏病患者行二尖瓣置换同期三尖瓣环成形术远期结果良好。
  • 同期三尖瓣环成形与远期三尖瓣反流分级改善及特定人群生存获益相关。

研究设计与样本

  • 单中心回顾性研究,纳入285例风湿性患者,单纯二尖瓣置换147例,同期三尖瓣环成形138例。
  • 三尖瓣反流严重程度按超声指南以0–3级评估。
  • 中位随访10.8年(四分位距6.8–14.5年)。

主要发现

  • 同期三尖瓣环成形患者远期三尖瓣反流分级改善的 odds 为3.4倍(多因素 logistic 回归)。
  • 术前中重度三尖瓣反流患者中,同期三尖瓣环成形与远期生存获益独立相关(HR 0.44,95%CI 0.23–0.87,p=0.018)。
  • 二尖瓣置换患者以女性为主,手术中位年龄59岁(四分位距48–68岁)。

临床怎么用

  • 风湿性心脏病患者行二尖瓣置换时,可考虑同期三尖瓣环成形以改善远期三尖瓣反流。
  • 术前存在中重度三尖瓣反流的风湿性患者,同期三尖瓣环成形可能带来远期生存获益。

局限性

  • 单中心回顾性研究,可能存在选择偏倚与混杂。
  • 样本量285例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Late tricuspid regurgitation is a common finding in patients with rheumatic valvular disease after mitral valve replacement surgery. However, the long-term benefit of concomitant tricuspid valve annuloplasty has not been established in this population. METHODS: This was a single-center retrospective study in a tertiary hospital. The final cohort included 285 rheumatic patients who underwent either isolated mitral valve replacement (147 patients) or mitral valve replacement with concomitant tricuspid valve annuloplasty (138 patients). Tricuspid regurgitation severity grade was assessed according to current echocardiography guidelines and graded using a 0 to 3 scale (none or trivial, mild, moderate, severe). RESULTS: Patients were followed for a total median duration of 10.8 (interquartile range, 6.8 to 14.5) years. The majority of patients undergoing mitral valve replacement were women, with a median age at operation of 59 (interquartile range, 48 to 68) years. Patients undergoing concomitant tricuspid valve annuloplasty had a 3.4-fold odds of improving their tricuspid regurgitation grade at long-term follow-up by multivariate logistic regression. Furthermore, concomitant tricuspid valve annuloplasty was independently associated with a long-term survival benefit in patients with preoperative moderate or severe tricuspid regurgitation (hazard ratio, 0.44; 95% confidence interval, 0.23 to 0.87; p = 0.018). CONCLUSIONS: This study demonstrates good long-term results in patients with rheumatic heart disease undergoing mitral valve replacement with concomitant tricuspid valve annuloplasty.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Itzhaki Ben Zadok O, Sagie A, Vaturi M, et al. Long-Term Outcomes After Mitral Valve Replacement and Tricuspid Annuloplasty in Rheumatic Patients. Ann Thorac Surg. 2018. PMID: 30617023. doi:10.1016/j.athoracsur.2018.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。